T. Barlas Et Al. , "Inactivation of KDM1A with the concurrent presence of MGUS in a patient with GIP-dependent Cushing's syndrome and the vanishing effect of octreotide therapy," EndoBridge 2023 , Antalya, Turkey, 2023
Barlas, T. Et Al. 2023. Inactivation of KDM1A with the concurrent presence of MGUS in a patient with GIP-dependent Cushing's syndrome and the vanishing effect of octreotide therapy. EndoBridge 2023 , (Antalya, Turkey).
Barlas, T., Kayhan, G., Yalçın, M. M., Cerit, E. T., Aktürk, M. Y., Törüner, F. S., ... Sözen, T. S.(2023). Inactivation of KDM1A with the concurrent presence of MGUS in a patient with GIP-dependent Cushing's syndrome and the vanishing effect of octreotide therapy . EndoBridge 2023, Antalya, Turkey
Barlas, TUĞBA Et Al. "Inactivation of KDM1A with the concurrent presence of MGUS in a patient with GIP-dependent Cushing's syndrome and the vanishing effect of octreotide therapy," EndoBridge 2023, Antalya, Turkey, 2023
Barlas, TUĞBA Et Al. "Inactivation of KDM1A with the concurrent presence of MGUS in a patient with GIP-dependent Cushing's syndrome and the vanishing effect of octreotide therapy." EndoBridge 2023 , Antalya, Turkey, 2023
Barlas, T. Et Al. (2023) . "Inactivation of KDM1A with the concurrent presence of MGUS in a patient with GIP-dependent Cushing's syndrome and the vanishing effect of octreotide therapy." EndoBridge 2023 , Antalya, Turkey.
@conferencepaper{conferencepaper, author={TUĞBA BARLAS Et Al. }, title={Inactivation of KDM1A with the concurrent presence of MGUS in a patient with GIP-dependent Cushing's syndrome and the vanishing effect of octreotide therapy}, congress name={EndoBridge 2023}, city={Antalya}, country={Turkey}, year={2023}}